PROPOFOL Safety Questions, PROPOFOL Answers


More Here>>Side Effects - FDA Reports 2006-2008

Medications A-Z:   A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Welcome! Patientsville.com provides unique information about PROPOFOL. Our extensive database of PROPOFOL adverse events and PROPOFOL warnings is updated regularly. If you have questions, you can post them to one of our health experts or ask others in our broad patient community.

>> Announcements
Check out our Hospital and Home Care Quality Reports.

Ask Our Health Experts about PROPOFOL

Do You Have a Question about Your Health?

Our Doctors and Nurses will Help You Understand Your Symptoms and Feel Better!
Private, Confidential and Discreet




PROPOFOL Safety Reports

Total PROPOFOL reports: 226.
PROPOFOL FDA safety alerts: 2001 2007 .
Reported deaths: 38    Reported hospitalizations: 46.
Take PROPOFOL Side Effects Survey or Share Your PROPOFOL Story. PROPOFOL Usage.

Showing 1-75 of 226 Next >

Physician from SPAIN reported PROPOFOL problem on June 20, 2006. Male patient, 65 years of age, was treated with PROPOFOL. After drug was administered, patient experienced the following problems/side effects: hepatitis acute. PROPOFOL dosage: unknown. Patient recovered.

PROPOFOL problem was reported by a Health Professional from AUSTRALIA on July 06, 2006. Female patient, weighting 143.3 lb, was treated with PROPOFOL. After drug was administered, patient experienced the following problems/side effects: hepatitis acute. PROPOFOL dosage: unknown. During the same period patient was treated with METOPROLOL TARTRATE, CEFTRIAXONE, ENOXAPARIN, METRONIDAZOLE, PARACETAMOL, TRAMADOL, ESOMEPRAZOLE MAGNESIUM TRIHYDRATE, MAXOLON. Patient recovered.

Health Professional from SPAIN reported PROPOFOL problem on July 06, 2006. Male patient was diagnosed with pneumonia and was treated with PROPOFOL. After drug was administered, patient experienced the following problems/side effects: hyperkalaemia, pyrexia, renal failure acute, rhabdomyolysis. PROPOFOL dosage: unknown. During the same period patient was treated with HYDROCORTISONE, MIDAZOLAM, MORPHINE, NORADRENALINE, INSULIN, RANITIDINE, CLEXANE. Patient was hospitalized. Patient died on 05/20/2006.

PROPOFOL problem was reported by a Health Professional from AUSTRALIA on July 06, 2006. Male patient, weighting 216.1 lb, was treated with PROPOFOL. After drug was administered, patient experienced the following problems/side effects: eye rolling, post procedural complication, somnolence. PROPOFOL dosage: unknown. During the same period patient was treated with MIDAZOLAM HYDROCHLORIDE, ALFENTANIL, MORPHINE, ZYRTEC, SEVOFLURANE, LAMISIL. Patient was hospitalized. Patient recovered.

Health Professional from AUSTRALIA reported PROPOFOL problem on July 06, 2006. Male patient, 76 years of age, weighting 176.4 lb, was treated with PROPOFOL. After drug was administered, patient experienced the following problems/side effects: hypotension, urticaria. PROPOFOL dosage: unknown. During the same period patient was treated with GLYCERYL TRINITRATE, MIDAZOLAM HYDROCHLORIDE, FENTANYL TRANSDERMAL SYSTEM, PANCURONIUM BROMIDE, VANCOMYCIN HYDROCHLORIDE, SERETIDE ACCUHALER, ASPIRIN, GLYCERYL TRINITRATE. Patient recovered.

PROPOFOL problem was reported by a Health Professional from SWITZERLAND on July 07, 2006. Female patient, 59 years of age, was diagnosed with induction of anaesthesia and was treated with PROPOFOL. After drug was administered, patient experienced the following problems/side effects: electroencephalogram abnormal. PROPOFOL dosage: unknown. Patient recovered.

Health Professional from SWITZERLAND reported PROPOFOL problem on July 07, 2006. Female patient, 46 years of age, was diagnosed with induction of anaesthesia and was treated with PROPOFOL. After drug was administered, patient experienced the following problems/side effects: electroencephalogram abnormal. PROPOFOL dosage: unknown. Patient recovered.

PROPOFOL problem was reported by a Health Professional from FRANCE on July 17, 2006. Male patient, 27 years of age, was treated with PROPOFOL. After drug was administered, patient experienced the following problems/side effects: acute pulmonary oedema, pancreatitis haemorrhagic. PROPOFOL dosage: unknown. During the same period patient was treated with LIDOCAINE. Patient died.

Pharmacist from UNITED STATES reported PROPOFOL problem on July 21, 2006. Male patient, 24 years of age, weighting 150.4 lb, was diagnosed with coma, convulsion and was treated with PROPOFOL. After drug was administered, patient experienced the following problems/side effects: acidosis, arrhythmia, blood methaemoglobin present, cardio-respiratory arrest, hypotension, metabolic acidosis, rhabdomyolysis, tachycardia. PROPOFOL dosage: 2MG/KG LOAD, 0.1MG/KG/MIN MAINTENANCE *TITRATED TO BURST SUPPRESSION. During the same period patient was treated with TRANXENE, PEPCID, KEPPRA, SINEMET, MIRAPEX, VARIOUS PRESSORS. Patient died on 06/08/2006.

PROPOFOL problem was reported by a Pharmacist from UNITED STATES on July 24, 2006. Male patient was diagnosed with sedation and was treated with PROPOFOL. After drug was administered, patient experienced the following problems/side effects: blood creatine phosphokinase increased, bradycardia, electrocardiogram qt corrected interval prolonged. PROPOFOL dosage: unknown. Patient recovered.

Pharmacist from UNITED STATES reported PROPOFOL problem on July 26, 2006. Male patient, 25 years of age, was diagnosed with sedation and was treated with PROPOFOL. After drug was administered, patient experienced the following problems/side effects: contraindication to medical treatment, dermatitis exfoliative, pruritus, stevens-johnson syndrome. PROPOFOL dosage: unknown. Patient was hospitalized. Patient recovered.

PROPOFOL problem was reported by a Health Professional from UNITED KINGDOM on July 21, 2006. Male patient, 29 years of age, was treated with PROPOFOL. After drug was administered, patient experienced the following problems/side effects: alanine aminotransferase increased, blood creatine phosphokinase increased, rhabdomyolysis. PROPOFOL dosage: unknown. During the same period patient was treated with FENTANYL, SUCCINYLCHOLINE CHLORIDE, RABEPRAZOLE, INHALERS. Patient was hospitalized. Patient recovered.

Health Professional from UNITED STATES reported PROPOFOL problem on July 26, 2006. Female patient, weighting 193.3 lb, was treated with PROPOFOL. After drug was administered, patient experienced the following problems/side effects: atelectasis, encephalopathy, intubation complication, pleural effusion. PROPOFOL dosage: unknown. During the same period patient was treated with NITROPRUSSIDE. Patient was hospitalized. Patient recovered.

PROPOFOL problem was reported by a Health Professional from UNITED KINGDOM on Aug 03, 2006. Male patient, 51 years of age, weighting 176.4 lb, was diagnosed with subdural haemorrhage, hypertension, blood cholesterol increased and was treated with PROPOFOL. After drug was administered, patient experienced the following problems/side effects: blood creatine phosphokinase increased, myoglobinuria, renal failure, rhabdomyolysis. PROPOFOL dosage: unknown. During the same period patient was treated with AMLODIPINE, ANADIN, ATORVASTATIN CALCIUM, RAMIPRIL, WARFARIN. Patient was hospitalized. Patient recovered.

Physician from UNITED STATES reported PROPOFOL problem on Aug 09, 2006. Male patient, 27 years of age, weighting 241.0 lb, was treated with PROPOFOL. After drug was administered, patient experienced the following problems/side effects: agitation, atrial fibrillation, blood creatine phosphokinase increased, blood pressure increased, myoglobin blood increased, propofol infusion syndrome, tachycardia, troponin increased. PROPOFOL dosage: unknown. Patient died on 04/02/2005.

PROPOFOL problem was reported by a Health Professional from UNITED STATES on Aug 14, 2006. Male patient, child 10 years of age, weighting 92.59 lb, was treated with PROPOFOL. After drug was administered, patient experienced the following problems/side effects: inadequate analgesia. PROPOFOL dosage: 300 MG DURING CASE IV BOLUS. Patient recovered.

Pharmacist from UNITED STATES reported PROPOFOL problem on Aug 21, 2006. Male patient, 19 years of age, weighting 154.3 lb, was diagnosed with anaesthesia and was treated with PROPOFOL. After drug was administered, patient experienced the following problems/side effects: chills, delayed recovery from anaesthesia, dystonia. PROPOFOL dosage: unknown. Patient was hospitalized. Patient recovered.

PROPOFOL problem was reported by a Pharmacist from UNITED STATES on Aug 23, 2006. Female patient was diagnosed with surgery and was treated with PROPOFOL. After drug was administered, patient experienced the following problems/side effects: no therapeutic response. PROPOFOL dosage: 200 MG 1 TIME IV BOLUS. Patient was hospitalized. Patient recovered.

Pharmacist from UNITED STATES reported PROPOFOL problem on Aug 24, 2006. Female patient, 51 years of age, weighting 127.9 lb, was diagnosed with colonoscopy, depression and was treated with PROPOFOL. After drug was administered, patient experienced the following problems/side effects: asthenopia, convulsion, delayed recovery from anaesthesia, enzyme abnormality, sensation of heaviness. PROPOFOL dosage: unknown. During the same period patient was treated with VENLAFAXINE. Patient was hospitalized. Patient recovered.

PROPOFOL problem was reported by a Health Professional from UNITED STATES on Sept 04, 2006. Female patient, 13 years of age, was diagnosed with anaesthesia and was treated with PROPOFOL. After drug was administered, patient experienced the following problems/side effects: cardiac arrest, procedural complication, respiratory arrest. PROPOFOL dosage: unknown. During the same period patient was treated with FENTANYL, MIDAZOLAM. Patient died.

Health Professional from JAPAN reported PROPOFOL problem on Sept 06, 2006. Female patient, 32 years of age, was treated with PROPOFOL. After drug was administered, patient experienced the following problems/side effects: haemoglobin decreased, hyponatraemia, metabolic acidosis, water intoxication. PROPOFOL dosage: unknown. During the same period patient was treated with FENTANEST. Patient recovered.

PROPOFOL problem was reported by a Pharmacist from UNITED STATES on Sept 12, 2006. Female patient, 29 years of age, was treated with PROPOFOL. After drug was administered, patient experienced the following problems/side effects: chromaturia. PROPOFOL dosage: unknown. Patient recovered.

Health Professional from UNITED STATES reported PROPOFOL problem on Sept 04, 2006. Female patient, 13 years of age, was diagnosed with anaesthesia and was treated with PROPOFOL. After drug was administered, patient experienced the following problems/side effects: cardiac arrest, respiratory arrest. PROPOFOL dosage: unknown. During the same period patient was treated with MIDAZOLAM, FENTANYL. Patient died.

PROPOFOL problem was reported by a Health Professional from UNITED STATES on Sept 18, 2006. Female patient, 71 years of age, was diagnosed with cerebral ischaemia and was treated with PROPOFOL. After drug was administered, patient experienced the following problems/side effects: lactic acidosis, multi-organ failure. PROPOFOL dosage: unknown. During the same period patient was treated with OXYGENATED FLUOROCARBON NUTRIENT EMULSION. Patient died.

Consumer or non-health professional from UNITED STATES reported PROPOFOL problem on Sept 21, 2006. Male patient, weighting 234.8 lb, was diagnosed with status epilepticus and was treated with PROPOFOL. After drug was administered, patient experienced the following problems/side effects: blood creatine phosphokinase increased, blood creatinine increased, cardiac arrest, metabolic acidosis, propofol infusion syndrome, ventricular tachycardia. PROPOFOL dosage: unknown. During the same period patient was treated with ACETAMINOPHEN, INSULIN, DEXAMETHASONE, LAMOTRIGINE, PENICILLIN G POTASSIUM, PHENOBARBITAL, PHENYTOIN, RANITIDINE. Patient died on 02/15/2006.

PROPOFOL problem was reported by a Physician from DENMARK on Sept 19, 2006. Female patient, weighting 136.7 lb, was diagnosed with anaesthesia and was treated with PROPOFOL. After drug was administered, patient experienced the following problems/side effects: anaphylactic reaction, angioneurotic oedema, anoxia, cardiac arrest, salivary hypersecretion. PROPOFOL dosage: 150 MG, INTRAVENOUS. During the same period patient was treated with COZAAR. Patient died on 03/30/2005.

Health Professional from UNITED STATES reported PROPOFOL problem on Oct 02, 2006. Male patient, 76 years of age, weighting 200.0 lb, was diagnosed with cardioversion and was treated with PROPOFOL. After drug was administered, patient experienced the following problems/side effects: sneezing, therapeutic response decreased. PROPOFOL dosage: 120 MG TOTAL DOSE- SPLIT IV BOLUS. Patient recovered.

PROPOFOL problem was reported by a Health Professional from UNITED STATES on Oct 05, 2006. Female patient was diagnosed with induction of anaesthesia and was treated with PROPOFOL. After drug was administered, patient experienced the following problems/side effects: angioneurotic oedema, dysphagia, dyspnoea. PROPOFOL dosage: 200 MG ANES INDUCTION IV PUSH. Patient recovered.

Physician from UNITED STATES reported PROPOFOL problem on Oct 02, 2006. Female patient, 55 years of age, was diagnosed with colonoscopy and was treated with PROPOFOL. After drug was administered, patient experienced the following problems/side effects: aggression, anticholinergic syndrome, atrioventricular block first degree, blood lactate dehydrogenase increased, blood pressure increased, disorientation, hyperreflexia, loss of consciousness, miosis. PROPOFOL dosage: unknown. During the same period patient was treated with FENTANYL. Patient recovered.

PROPOFOL problem was reported by a Health Professional from UNITED STATES on Sept 18, 2006. Female patient, 71 years of age, was diagnosed with cerebral ischaemia and was treated with PROPOFOL. After drug was administered, patient experienced the following problems/side effects: lactic acidosis, multi-organ failure. PROPOFOL dosage: unknown. During the same period patient was treated with OXYGENATED FLUOROCARBON NUTIRENT EMULSION, ARTIFICIAL CEREBROSPINAL FLUID, ARTIFICIAL CEREBROSPINAL FLUID. Patient died.

Pharmacist from UNITED STATES reported PROPOFOL problem on Oct 05, 2006. Male patient, 21 years of age, weighting 174.2 lb, was diagnosed with sedation and was treated with PROPOFOL. After drug was administered, patient experienced the following problems/side effects: acidosis hyperchloraemic, cardiomyopathy, ejection fraction decreased, gastrointestinal oedema, haemophilus infection, infusion related reaction, intracranial pressure increased, lactic acidosis. PROPOFOL dosage: unknown. Patient recovered.

PROPOFOL problem was reported by a Physician from ISRAEL on Oct 10, 2006. Female patient, 55 years of age, was diagnosed with induction of anaesthesia, maintenance of anaesthesia and was treated with PROPOFOL. After drug was administered, patient experienced the following problems/side effects: acute myocardial infarction, anaesthetic complication, apnoea, cardiac failure congestive, cardiomyopathy. PROPOFOL dosage: unknown. During the same period patient was treated with FENTANYL, ROCURONIUM, NITROUS OXIDE IN OXYGEN, ISOFLURANE. Patient recovered.

Health Professional from UNITED KINGDOM reported PROPOFOL problem on Oct 19, 2006. Female patient, weighting 17.20 lb, was treated with PROPOFOL. After drug was administered, patient experienced the following problems/side effects: diaphragmatic disorder, muscle necrosis, respiratory arrest. PROPOFOL dosage: unknown. During the same period patient was treated with ATRACURIUM BESYLATE, DESFLURANE, AUGMENTIN. Patient was hospitalized and became disabled. Patient died.

PROPOFOL problem was reported by a Pharmacist from UNITED STATES on Oct 26, 2006. Female patient, 47 years of age, weighting 319.7 lb, was diagnosed with life support and was treated with PROPOFOL. After drug was administered, patient experienced the following problems/side effects: pyrexia. PROPOFOL dosage: unknown. Patient was hospitalized and became disabled. Patient recovered.

Health Professional from JAPAN reported PROPOFOL problem on Oct 25, 2006. Female patient, 80 years of age, was diagnosed with maintenance of anaesthesia, epidural anaesthesia, induction of anaesthesia, hypertension and was treated with PROPOFOL. After drug was administered, patient experienced the following problems/side effects: hypotension, pulse absent. PROPOFOL dosage: unknown. During the same period patient was treated with ANAPEINEECTION, BUTORPHANOL TARTRATE, NIFEDIPINE, VALSARTAN. Patient recovered.

PROPOFOL problem was reported by a Physician from SWITZERLAND on Oct 30, 2006. Male patient, 24 years of age, was diagnosed with sedation and was treated with PROPOFOL. After drug was administered, patient experienced the following problems/side effects: bradycardia, brain oedema, hyperkalaemia, propofol infusion syndrome, renal failure acute, rhabdomyolysis. PROPOFOL dosage: unknown. During the same period patient was treated with METHYLPREDNISOLONE. Patient died.

Physician from SWITZERLAND reported PROPOFOL problem on Oct 31, 2006. Male patient, 24 years of age, was diagnosed with sedation and was treated with PROPOFOL. After drug was administered, patient experienced the following problems/side effects: acute respiratory distress syndrome, aspiration, bradycardia, brain oedema, cardiac failure, hyperkalaemia, inflammation, propofol infusion syndrome, renal failure. PROPOFOL dosage: 2.6 MG/KG, QH, INTRAVENOUS. During the same period patient was treated with METHYLPREDNISOLONE, EPINEPHRINE. Patient died.

PROPOFOL problem was reported by a Health Professional from AUSTRALIA on May 18, 2006. Male patient, 76 years of age, weighting 176.4 lb, was treated with PROPOFOL. After drug was administered, patient experienced the following problems/side effects: hypotension, urticaria. PROPOFOL dosage: unknown. During the same period patient was treated with GLYCERYL TRINITRATE, SERETIDE ACCUHALER, ASPIRIN, GLYCERYL TRINITRATE, MIDAZOLAM, FENTANYL, PANCURONIUM BROMIDE, VANCOMYCIN HYDROCHLORIDE. Patient recovered.

Health Professional from JAPAN reported PROPOFOL problem on Oct 25, 2006. Female patient, 55 years of age, weighting 121.3 lb, was diagnosed with induction of anaesthesia, maintenance of anaesthesia, hypotension and was treated with PROPOFOL. After drug was administered, patient experienced the following problems/side effects: angioneurotic oedema, intubation complication, toxic epidermal necrolysis. PROPOFOL dosage: unknown. During the same period patient was treated with VECURONIUM BROMIDE, OXYGEN MEDICAL USE, NITROUS OXIDE W, SEVOFLURANE, NITROPRUSSIDE. Patient died.

PROPOFOL problem was reported by a Physician from CANADA on Nov 13, 2006. Female patient, 31 years of age, was diagnosed with status epilepticus, intubation and was treated with PROPOFOL. After drug was administered, patient experienced the following problems/side effects: diabetes insipidus, encephalopathy, hypotension, hypovolaemia, ischaemia, maternal condition affecting foetus, procedural complication. PROPOFOL dosage: 200 MG IN INCREMENTAL DOSES. During the same period patient was treated with THIOPENTAL. Patient died.

Consumer or non-health professional from UNITED STATES reported PROPOFOL problem on Nov 20, 2006. Male patient, 70 years of age, weighting 183.0 lb, was diagnosed with sedation and was treated with PROPOFOL. After drug was administered, patient experienced the following problems/side effects: infusion related reaction, infusion site rash, rash erythematous. PROPOFOL dosage: unknown. Patient recovered.

PROPOFOL problem was reported by a Physician from CHINA on Nov 22, 2006. Female patient, 49 years of age, weighting 121.3 lb, was diagnosed with epidermoid cyst excision, anaesthesia, induction of anaesthesia and was treated with PROPOFOL. After drug was administered, patient experienced the following problems/side effects: retinal artery occlusion. PROPOFOL dosage: unknown. During the same period patient was treated with ATROPINE, MIDAZOLAM, VECURONIUM BROMIDE, FENTANYL. Patient recovered.

Pharmacist from UNITED STATES reported PROPOFOL problem on Nov 27, 2006. Female patient, 23 years of age, weighting 215.8 lb, was diagnosed with endoscopic retrograde cholangiopancreatography, nausea and was treated with PROPOFOL. After drug was administered, patient experienced the following problems/side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood bilirubin increased, infusion site erythema, infusion site mass. PROPOFOL dosage: unknown. During the same period patient was treated with ZOFRAN. Patient recovered.

PROPOFOL problem was reported by a Pharmacist from UNITED STATES on Nov 30, 2006. Male patient, 65 years of age, was diagnosed with agitation and was treated with PROPOFOL. After drug was administered, patient experienced the following problems/side effects: torsade de pointes. PROPOFOL dosage: unknown. Patient was hospitalized. Patient recovered.

Health Professional from UNITED STATES reported PROPOFOL problem on Aug 07, 2006. Female patient was diagnosed with angioneurotic oedema and was treated with PROPOFOL. After drug was administered, patient experienced the following problems/side effects: angioneurotic oedema. PROPOFOL dosage: unknown. Patient recovered.

PROPOFOL problem was reported by a Physician from UNITED STATES on Sept 19, 2006. Female patient, 29 years of age, weighting 150.0 lb, was diagnosed with sedation and was treated with PROPOFOL. After drug was administered, patient experienced the following problems/side effects: angioneurotic oedema, eye pruritus, paraesthesia, swollen tongue, urticaria. PROPOFOL dosage: unknown. During the same period patient was treated with LIDOCAINE. Patient recovered.

Physician from UNITED STATES reported PROPOFOL problem on Sept 19, 2006. Female patient, 33 years of age, weighting 185.0 lb, was treated with PROPOFOL. After drug was administered, patient experienced the following problems/side effects: bronchospasm. PROPOFOL dosage: unknown. During the same period patient was treated with VERSED, FENTANYL, LIDOCAINE, CLEOCIN, ATRACURIUM BESYLATE. Patient recovered.

PROPOFOL problem was reported by a Physician from UNITED STATES on Sept 19, 2006. Female patient, 65 years of age, weighting 120.0 lb, was treated with PROPOFOL. After drug was administered, patient experienced the following problems/side effects: chest pain, hypersensitivity. PROPOFOL dosage: unknown. Patient recovered.

Physician from UNITED STATES reported PROPOFOL problem on Sept 19, 2006. Female patient, 67 years of age, weighting 139.0 lb, was diagnosed with sedation and was treated with PROPOFOL. After drug was administered, patient experienced the following problems/side effects: angioneurotic oedema. PROPOFOL dosage: unknown. Patient recovered.

PROPOFOL problem was reported by a Physician from AUSTRIA on Nov 28, 2006. Male patient, 66 years of age, was diagnosed with sedation and was treated with PROPOFOL. After drug was administered, patient experienced the following problems/side effects: propofol infusion syndrome. PROPOFOL dosage: 1-3 MG/KGKG PLUS BOLI. During the same period patient was treated with HALOPERIDOL, CLONIDIN, NORADRENALIN, DOBUTAMIN, ACETAMINOPHEN, PIRITRAMIDE. Patient was hospitalized. Patient recovered.

Health Professional from UNITED STATES reported PROPOFOL problem on July 26, 2006. Female patient, weighting 192.9 lb, was treated with PROPOFOL. After drug was administered, patient experienced the following problems/side effects: atelectasis, atrial fibrillation, encephalopathy, herpes zoster, intubation complication, nasal cavity mass, pleural effusion. PROPOFOL dosage: unknown. During the same period patient was treated with NITROPRUSSIDE, LOTENSIN, NOVOLIN, BYETTA, TOPAMAX, PROTONIX, ASCORBIC ACID, OMEGA. Patient was hospitalized. Patient recovered.

PROPOFOL problem was reported by a Health Professional from POLAND on Dec 04, 2006. Female patient, child 4 years of age, was treated with PROPOFOL. After drug was administered, patient experienced the following problems/side effects: hepatomegaly, hyperkalaemia, hypotension, international normalised ratio increased, lipids abnormal, metabolic acidosis, propofol infusion syndrome, rhabdomyolysis, tachycardia. PROPOFOL dosage: unknown. Patient died.

Health Professional from UNITED KINGDOM reported PROPOFOL problem on Dec 07, 2006. Male patient, 14 years of age, weighting 90.39 lb, was diagnosed with anaesthesia, inflammation, procedural pain, gastric perforation and was treated with PROPOFOL. After drug was administered, patient experienced the following problems/side effects: hepatotoxicity. PROPOFOL dosage: unknown. During the same period patient was treated with SEVOFLURANE, CEFUROXIME, DEXAMETHASONE, DICLOFENAC, MIDAZOLAM, MORPHINE, OMEPRAZOLE, ACETAMINOPHEN. Patient was hospitalized. Patient recovered.

PROPOFOL problem was reported by a Health Professional from UNITED STATES on Dec 15, 2006. Female patient, weighting 18.52 lb, was treated with PROPOFOL. After drug was administered, patient experienced the following problems/side effects: delirium, depressed mood, irritability, pyrexia, respiratory syncytial virus infection, rhinovirus infection. PROPOFOL dosage: 10MG ONE TIME BOLUS IV BOLUS. Patient was hospitalized. Patient recovered.

Physician from UNITED KINGDOM reported PROPOFOL problem on Dec 01, 2006. Male patient, 14 years of age, weighting 90.39 lb, was diagnosed with anaesthesia and was treated with PROPOFOL. After drug was administered, patient experienced the following problems/side effects: hepatotoxicity. PROPOFOL dosage: unknown. During the same period patient was treated with SEVOFLURANE, CEFUROXIME, DEXAMETHASONE, DICLOFENAC, MIDAZOLAM HYDROCHLORIDE, MORPHINE, OMEPRAZOLE, ACETAMINOPHEN. Patient was hospitalized. Patient recovered.

PROPOFOL problem was reported by a Physician from UNITED KINGDOM on Dec 01, 2006. Female patient, 19 years of age, weighting 116.8 lb, was diagnosed with anaesthesia and was treated with PROPOFOL. After drug was administered, patient experienced the following problems/side effects: dyskinesia. PROPOFOL dosage: unknown. During the same period patient was treated with MICROGYNON. Patient was hospitalized. Patient recovered.

Health Professional from UNITED KINGDOM reported PROPOFOL problem on Dec 07, 2006. Female patient, 19 years of age, weighting 116.8 lb, was diagnosed with anaesthesia, contraception and was treated with PROPOFOL. After drug was administered, patient experienced the following problems/side effects: dyskinesia. PROPOFOL dosage: unknown. During the same period patient was treated with MICROGYNON. Patient was hospitalized. Patient recovered.

PROPOFOL problem was reported by a Pharmacist from UNITED STATES on Dec 18, 2006. Male patient, 16 years of age, weighting 140.0 lb, was diagnosed with surgery and was treated with PROPOFOL. After drug was administered, patient experienced the following problems/side effects: muscle spasms, pain. PROPOFOL dosage: unknown. Patient was hospitalized. Patient recovered.

Health Professional from UNITED KINGDOM reported PROPOFOL problem on Nov 02, 2006. Male patient, 37 years of age, was diagnosed with cardioversion and was treated with PROPOFOL. After drug was administered, patient experienced the following problems/side effects: abnormal behaviour, confusional state. PROPOFOL dosage: unknown. During the same period patient was treated with MIDAZOLAM HYDROCHLORIDE. Patient recovered.

PROPOFOL problem was reported by a Health Professional from UNITED KINGDOM on Dec 27, 2006. Female patient, 46 years of age, was diagnosed with antibiotic prophylaxis, hypotension, anaesthesia reversal and was treated with PROPOFOL. After drug was administered, patient experienced the following problems/side effects: abdominal distension, acute hepatic failure, coagulopathy, hepatomegaly, oxygen saturation decreased, somnolence, stridor, tachycardia, tachypnoea. PROPOFOL dosage: unknown. During the same period patient was treated with AMOXICILLIN, DICLOFENAC, EPHEDRINE, FENTANYL, GLYCOPYRROLATE, ISOFLURANE, MORPHINE, NEOSTIGMINE. Patient recovered.

Health Professional from POLAND reported PROPOFOL problem on Dec 11, 2006. Female patient, child 4 years of age, was treated with PROPOFOL. After drug was administered, patient experienced the following problems/side effects: circulatory collapse, hepatic function abnormal, hepatic trauma, hepatomegaly, hyperkalaemia, hyperlipidaemia, hypoperfusion, hypotension, hypoxia. PROPOFOL dosage: unknown. Patient died.

PROPOFOL problem was reported by a Physician from on Dec 06, 2006. Male patient, 66 years of age, was diagnosed with sedation and was treated with PROPOFOL. After drug was administered, patient experienced the following problems/side effects: atrial flutter, propofol infusion syndrome. PROPOFOL dosage: 1-3 MG/KG2 PLUS BOLUS. During the same period patient was treated with HALOPERIDOL, CLONIDIN, NORADRENALIN, DOBUTAMIN, ACETAMINOPHEN, PIRITRAMIDE. Patient was hospitalized. Patient recovered.

Health Professional from UNITED KINGDOM reported PROPOFOL problem on Dec 18, 2006. Female patient, 46 years of age, was diagnosed with antibiotic prophylaxis, hypotension, neuromuscular blockade reversal and was treated with PROPOFOL. After drug was administered, patient experienced the following problems/side effects: abdominal distension, acute hepatic failure, hypotension, oxygen saturation decreased, post procedural complication, somnolence, stridor, tachycardia, tachypnoea. PROPOFOL dosage: unknown. During the same period patient was treated with AMOXICILLIN, DICLOFENAC, EPHEDRINE SUL CAP, FENTANYL, GLYCOPYRROLATE, ISOFLURANE, MORPHINE, NEOSTIGMINE. Patient recovered.

PROPOFOL problem was reported by a Consumer or non-health professional from JAPAN on June 26, 2007. Female patient, 76 years of age, weighting 147.7 lb, was diagnosed with anaesthesia, hyperlipidaemia, hypertension and was treated with PROPOFOL. After drug was administered, patient experienced the following problems/side effects: cystitis interstitial, pollakiuria, swollen tongue. PROPOFOL dosage: unknown. During the same period patient was treated with ATORVASTATIN, VALSARTAN. Patient was hospitalized. Patient recovered.

Health Professional from JAPAN reported PROPOFOL problem on June 29, 2007. Male patient, 58 years of age, was diagnosed with induction of anaesthesia, maintenance of anaesthesia and was treated with PROPOFOL. After drug was administered, patient experienced the following problems/side effects: acute pulmonary oedema, lung disorder. PROPOFOL dosage: unknown. During the same period patient was treated with FENTANYL CITRATE, VECURONIUM BROMIDE, SEVOFLURANE. Patient recovered.

PROPOFOL problem was reported by a Health Professional from UNITED KINGDOM on June 29, 2007. Female patient, 55 years of age, weighting 132.3 lb, was diagnosed with induction of anaesthesia, musculoskeletal pain and was treated with PROPOFOL. After drug was administered, patient experienced the following problems/side effects: myotonia. PROPOFOL dosage: unknown. During the same period patient was treated with GABAPENTIN, ALFENTANIL, FENTANYL. Patient was hospitalized. Patient recovered.

Health Professional from CHINA reported PROPOFOL problem on June 28, 2007. Female patient, 21 years of age, was diagnosed with anaesthesia, uterus evacuation and was treated with PROPOFOL. After drug was administered, patient experienced the following problems/side effects: cold sweat, dizziness, headache, loss of consciousness, malaise. PROPOFOL dosage: unknown. During the same period patient was treated with OXYTOCIN. Patient recovered.

PROPOFOL problem was reported by a Health Professional from JAPAN on July 06, 2007. Male patient, 63 years of age, was diagnosed with induction of anaesthesia and was treated with PROPOFOL. After drug was administered, patient experienced the following problems/side effects: arteriospasm coronary. PROPOFOL dosage: unknown. During the same period patient was treated with FENTANYL TRANSDERMAL SYSTEM, VECURONIUM BROMIDE. Patient recovered.

Physician from UNITED STATES reported PROPOFOL problem on July 05, 2007. Male patient, weighting 200.0 lb, was diagnosed with sedation and was treated with PROPOFOL. After drug was administered, patient experienced the following problems/side effects: chills, post procedural complication, pyrexia. PROPOFOL dosage: unknown. Patient recovered.

PROPOFOL problem was reported by a Pharmacist from UNITED STATES on July 11, 2007. Female patient, weighting 165.3 lb, was diagnosed with anaesthesia and was treated with PROPOFOL. After drug was administered, patient experienced the following problems/side effects: abnormal behaviour, agitation, anticholinergic syndrome, delirium, disorientation, post procedural complication. PROPOFOL dosage: 200 MG ONCE IV. Patient was hospitalized. Patient recovered.

Pharmacist from UNITED STATES reported PROPOFOL problem on July 12, 2007. Male patient, weighting 209.4 lb, was diagnosed with anaesthesia and was treated with PROPOFOL. After drug was administered, patient experienced the following problems/side effects: chills, post procedural complication, pyrexia, tremor. PROPOFOL dosage: unknown. Patient recovered.

PROPOFOL problem was reported by a Pharmacist from UNITED STATES on July 12, 2007. Male patient, weighting 174.2 lb, was diagnosed with anaesthesia, cardiac operation and was treated with PROPOFOL. After drug was administered, patient experienced the following problems/side effects: chills, pyrexia, tremor. PROPOFOL dosage: unknown. Patient recovered.

Physician from UNITED STATES reported PROPOFOL problem on July 17, 2007. Male patient, 54 years of age, weighting 170.0 lb, was diagnosed with anaesthesia and was treated with PROPOFOL. After drug was administered, patient experienced the following problems/side effects: dizziness, fatigue, feeling drunk, nausea, post procedural complication, somnolence. PROPOFOL dosage: unknown. Patient recovered.

PROPOFOL problem was reported by a Pharmacist from UNITED STATES on July 20, 2007. Male patient, 73 years of age, weighting 184.0 lb, was diagnosed with sedation and was treated with PROPOFOL. After drug was administered, patient experienced the following problems/side effects: chills, post procedural complication, postoperative fever. PROPOFOL dosage: 300MG CONT IV. Patient was hospitalized. Patient recovered.

Health Professional from UNITED KINGDOM reported PROPOFOL problem on July 09, 2007. Female patient, 55 years of age, weighting 132.3 lb, was diagnosed with induction of anaesthesia, neuralgia, maintenance of anaesthesia and was treated with PROPOFOL. After drug was administered, patient experienced the following problems/side effects: dystonia, myoclonus, myotonia. PROPOFOL dosage: 150 MG. During the same period patient was treated with ALFENTANIL, FENTANYL, GABAPENTIN, ISOFLURANE, DEXAMETHASONE, ACETAMINOPHEN. Patient recovered.

Showing 1-75 of 226 Next >

Ask Our Patient Community about PROPOFOL

Select a Medication and Click to Access Reports about Side Effects and Adverse Reactions

A  B  C  D  E  F  G  H  I  J  K  L  M  N  O  P  Q  R  S  T  U  V  W  X  Y  Z

This drug has as active FDA Safety Alert This drug has an active FDA Safety Alert
A
Abacavir sulfate
Abatacept
Abilify
Acamprosate calcium
AccuprilThis drug has as active FDA Safety Alert
AccutaneThis drug has as active FDA Safety Alert
AceonThis drug has as active FDA Safety Alert
Aciphex
Actiq (fentanyl citrate)
ActimmuneThis drug has as active FDA Safety Alert
(aripiprazole) (quinapril) (isotretinoin) (perindopril) (rabeprazole) (interferon gamma-1b)
ActonelThis drug has as active FDA Safety Alert (risedronate)
Actoplus MetThis drug has as active FDA Safety Alert (pioglitazone)
ActosThis drug has as active FDA Safety Alert (pioglitazone)
AcuTect (technetium Tc 99m apcitide)
Adefovir dipivoxil
Advair Diskus(Fluticasone propionate; Salmeterol xinafoate)
AdderallThis drug has as active FDA Safety Alert (amphetamine salts)
Agenerase (amprenavir)
Aggrastat (tirofiban)
Alamast (pemirolast)
AlendronateThis drug has as active FDA Safety Alert
AlemtuzumabThis drug has as active FDA Safety Alert
AleveThis drug has as active FDA Safety Alert (naproxen sodium)
Alfuzosin
Alinia (nitazoxanide)
Alimta (pemetrexed)
Alitretinoin
Almotriptan malateThis drug has as active FDA Safety Alert
Alosetron hydrochloride
Aloxi (palonosetron)
Alrex (loteprednol etabonate)
AltaceThis drug has as active FDA Safety Alert (ramipril)
Ambien (zolpidem tartrate)
AmergeThis drug has as active FDA Safety Alert (naratriptan)
Aminolevulinic acid
AmiodaroneThis drug has as active FDA Safety Alert
Amitiza (lubiprostone)
AmnesteemThis drug has as active FDA Safety Alert (isotretinoin)
Amphadase (hyaluronidase)
luronidase)
Amphetamine saltsThis drug has as active FDA Safety Alert
Amprenavir
AnaproxThis drug has as active FDA Safety Alert (naproxen sodium)
Angiomax (bivalirudin)
Anidulafungin
Antagon (ganirelix acetate)
Anthelios SX (avobenzone, ecamsule, octocrylene)
Apidra (insulin glulisine recombinant)
Apokyn (apomorphine)
Aprepitant
Aprotinin
Aptivus (tipranavir)
AranespThis drug has as active FDA Safety Alert (darbepoetin alpha)
Arava (leflunomide)
Arformoterol

Argatroban
ArediaThis drug has as active FDA Safety Alert (pamidronate)
Aripiprazole
Arixtra (fondaparinux)
Aromasin (exemestane)
Arranon (nelarabine)
Arsenic trioxide
Aspirin
Atacand (candesartan cilexetil)
Atazanavir sulfate
AtomoxetineThis drug has as active FDA Safety Alert
Avastin (bevacizumab)
Avelox (moxifloxacin)
Avobenzone, Ecamsule, Octocrylene
Avodart (dutasteride)
Avonex (interferon beta-1a)
AxertThis drug has as active FDA Safety Alert (almotriptan malate)
Azacitidine
Azilect (rasagiline)
Azopt (brinzolamide)

back to top

B
Balsalazide disodium
Baraclude (entecavir)
BenazeprilThis drug has as active FDA Safety Alert
Benicar (olmesartan medoxomil)
Bevacizumab
Bexarotene
BextraThis drug has as active FDA Safety Alert (valdecoxib)
BiaxinThis drug has as active FDA Safety Alert (clarithromycin)
Bimatoprost
Bivalirudin
BonivaThis drug has as active FDA Safety Alert (ibandronate)
Bortezomib
Brinzolamide
Brovana (arformoterol)
BupropionThis drug has as active FDA Safety Alert
Butisol sodium
Byetta (exenatide)


back to top

C
Calfactant
CampathThis drug has as active FDA Safety Alert (alemtuzumab)
Campral (acamprosate calcium)
Cancidas (caspofungin)
Candesartan cilexetil
Capecitabine
CapotenThis drug has as active FDA Safety Alert (captopril)
CaptoprilThis drug has as active FDA Safety Alert
CarbamazepineThis drug has as active FDA Safety Alert
CarbatrolThis drug has as active FDA Safety Alert (carbamazepine)
Carbrital (pentobarbital and carbromal)
Caspofungin
Cefditoren pivoxil
CefepimeThis drug has as active FDA Safety Alert
CeftriaxoneThis drug has as active FDA Safety Alert
CelebrexThis drug has as active FDA Safety Alert (celecoxib)
CelecoxibThis drug has as active FDA Safety Alert
CelexaThis drug has as active FDA Safety Alert (citalopram hydrobromide)
Cetrorelix acetate
Cetrotide (cetrorelix acetate)
Cetuximab
Cevimeline
ChantixThis drug has as active FDA Safety Alert (varenicline)
Cialis (tadalafil)
Cilostazol
Cinacalcet
Cirlesonide
CitalopramThis drug has as active FDA Safety Alert
ClaravisThis drug has as active FDA Safety Alert (isotretinoin)
ClarithromycinThis drug has as active FDA Safety Alert
Clarinex (desloratadine)
Clolar (clofarabine)
Clofarabine
Clozapine
Clozaril (clozapine)
CodeineThis drug has as active FDA Safety Alert
Colazal (balsalazide disodium)
Colesevelam
ColistimethateThis drug has as active FDA Safety Alert
Coly-Mycin M (colistimethate)This drug has as active FDA Safety Alert
Comtan (entacapone)
Concerta (methylphenidate)
Conivaptan
CordaroneThis drug has as active FDA Safety Alert (amiodarone)
CrestorThis drug has as active FDA Safety Alert (rosuvastatin calcium)
Cubicin (daptomycin)
Curosurf (poractant alfa)
CylertThis drug has as active FDA Safety Alert (pemoline)
CymbaltaThis drug has as active FDA Safety Alert (duloxetine)
CytotecThis drug has as active FDA Safety Alert (misoprostol)

back to top

D
Dacogen (decitabine)
Dalfopristin
Dalmane (flurazepam)
Daptomycin
Darbepoetin alphaThis drug has as active FDA Safety Alert
Darifenacin
Darunavir
Dasatinib
Daytrana (methylphenidate transdermal)
DDAVPThis drug has as active FDA Safety Alert (desmopressin)
DDAVP Nasal SprayThis drug has as active FDA Safety Alert (demopressin)
DDAVP Rhinal TubeThis drug has as active FDA Safety Alert (desmopressin)
DDVPThis drug has as active FDA Safety Alert (desmopressin
Decitabine
Deferasirox
Definity (perflutren lipid microspheres)
DepaconThis drug has as active FDA Safety Alert (valproate)
DepakeneThis drug has as active FDA Safety Alert (valproate)
DepakoteThis drug has as active FDA Safety Alert (valproate)
Desloratadine
DesmopressinThis drug has as active FDA Safety Alert
Detrol (tolterodine tartrate)
terodine tartrate)
Dexedrine (dextroamphetamine sulfate)
Dexmedetomidine
Dexmethylphenidate HCl
> Dextroamphetamine sulfate
Diastat AcuDialThis drug has as active FDA Safety Alert
Diazepam rectal gelThis drug has as active FDA Safety Alert
DidronelThis drug has as active FDA Safety Alert (etidronate)
DiprivanThis drug has as active FDA Safety Alert (propofol)
Dofetilide
Doral (quazepam)
Doxercalcif
Drospirenone
DuloxetineThis drug has as active FDA Safety Alert
DuragesicThis drug has as active FDA Safety Alert (fentanyl transdermal system)
Dutasteride

back to top

E

Eculizumab
Edetate disodium
Efalizumab
Efavirenz
EffexorThis drug has as active FDA Safety Alert (venlafaxine)
Elestat (epinastine)
EletriptanThis drug has as active FDA Safety Alert
Elidel (pimecrolimus)
Ellence (epirubicin)
Eloxatin (oxaliplatin)
Emend (aprepitant)
Emtricitabine
Emtriva (emtricitabine)
Enablex (darifenacin)
Enalapril / EnalaprilatThis drug has as active FDA Safety Alert
Endrate (edetate disodium)
Enfuvirtide
Entacapone
Entecavir
Epinastine
Epirubicin
Eplerenone
Epoetin alfaThis drug has as active FDA Safety Alert
EpogenThis drug has as active FDA Safety Alert (epoetin alfa)
Eptifibatide
EquetroThis drug has as active FDA Safety Alert (carbamazepine)
Eraxis (anidulafungin)
Erbitux (cetuximab)
Ertaczo (sertaconazole)
EscitalopramThis drug has as active FDA Safety Alert
Estazolam
Eszopiclone
Ethchlorvynol

Ethinyl estradiol
EtidronateThis drug has as active FDA Safety Alert
Evoxac (cevimeline)
Exelon (rivastigmine tartrate)
Exenatide
Exjade (deferasirox)
Exemestane
Extraneal (icodextrin)
Ezetimibe
Ezetimibe/simvastatin

back to top

F
Factive (gemifloxacin mesylate)
Faslodex (fulvestrant)
FelbamateThis drug has as active FDA Safety Alert
FelbatolThis drug has as active FDA Safety Alert (felbamate)
Fentanyl buccal tabletsThis drug has as active FDA Safety Alert
Fentanyl citrate
Fentanyl transdermal systemThis drug has as active FDA Safety Alert
FentoraThis drug has as active FDA Safety Alert (fentanyl buccal tablets)
Ferrlecit (sodium ferric gluconate complex)
Fleet Accu-PrepThis drug has as active FDA Safety Alert (sodium phosphate)
Fleet Phospho-SodaThis drug has as active FDA Safety Alert (sodium phosphate)
FluoxetineThis drug has as active FDA Safety Alert
Flurazepam
Fluticasone propionate
FluvoxamineThis drug has as active FDA Safety Alert
Focalin (dexmethylphenidate)
Focalin XR (dexmethylphenidate)
Fomivirsen
Fondaparinux
Foradil (formoterol fumarate)
Formoterol fumarate
FosamaxThis drug has as active FDA Safety Alert (alendronate)
FosinoprilThis drug has as active FDA Safety Alert
FrovaThis drug has as active FDA Safety Alert (frovatriptan succinate)
Frovatriptan succinateThis drug has as active FDA Safety Alert
Fulvestrant
Fuzeon (enfuvirtide)

G
GabapentinThis drug has as active FDA Safety Alert
GabitrilThis drug has as active FDA Safety Alert (tiagabine)
Gadobenate DimeglumineThis drug has as active FDA Safety Alert
GadodiamideThis drug has as active FDA Safety Alert
GadoliniumThis drug has as active FDA Safety Alert
Gadopentetate DimeglumineThis drug has as active FDA Safety Alert
GadoteridolThis drug has as active FDA Safety Alert
GadoversetamideThis drug has as active FDA Safety Alert
GalantamineThis drug has as active FDA Safety Alert
Ganirelix acetate
GatifloxacinThis drug has as active FDA Safety Alert
GefitinibThis drug has as active FDA Safety Alert
Gemifloxacin mesylate
Gemtuzumab ozogamicin
Geodon (ziprasidone)
Gleevec (imatinib mesylate)

back to top

H
Halcion (triazolam)
HaldolThis drug has as active FDA Safety Alert (haloperidol)
Haloperidol
This drug has as active FDA Safety Alert
Hectorol (doxercalcif)
Hepsera (adefovir dipivoxil)
Hyaluronidase
Hydase (hyaluronidase)
Human Secretin

back to top

I
IbandronateThis drug has as active FDA Safety Alert
Ibuprofen
Icodextrin
Iloprost
Imatinib mesylate
Increlex (Mecasermin [rDNA origin]
Infasurf Preservative Free (calfactant)
ImitrexThis drug has as active FDA Safety Alert (sumatriptan)
Innohep (tinzaparin)
Inspra (eplerenone)
Insulin Aspart recombinant
Insulin Detemir recombinant
Insulin Glargine recombinant

Insulin Glulisine recombinant

Intron A (interferon alfa-2b)
Integrilin (eptifibatide)
ifibatide)
Interferon alfa-2b
Interferon beta-1a
Interferon gamma-1bThis drug has as active FDA Safety Alert
Invega (paliperidone)
Iplex  (mecasermin rinfabate)
IressaThis drug has as active FDA Safety Alert (gefitinib)
IsotretinoinThis drug has as active FDA Safety Alert

back to top

J
Januvia (sitagliptin phosphate)

back to top

K
Kaletra (lopinavir; ritonavir)
Kepivance (palifermin)
KeppraThis drug has as active FDA Safety Alert (levetiracetam)
Ketek (telithromycin)
Ketotifen fumarate

back to top

L
LamictalThis drug has as active FDA Safety Alert (lamotrigine)
LamotrigineThis drug has as active FDA Safety Alert
Lantus (insulin glargine recombinant)
Leflunomide
Lenalidomide
Lepirudin recombinant
Levalbuterol
Levemir (insulin detemir recombinant)
LevetiracetamThis drug has as active FDA Safety Alert
Levitra (vardenafil)
Levonorgestrel
Levothyroxine sodium
Levulan Kerastick (aminolevulinic acid)
LexaproThis drug has as active FDA Safety Alert (escitalopram)
Lindane
Linezolid
This drug has as active FDA Safety Alert
LisinoprilThis drug has as active FDA Safety Alert
Lopinavir/ritonavir
Lotemax (loteprednol etabonate)
LotensinThis drug has as active FDA Safety Alert (benazepril)
Loteprednol etabonate
Lotronex (alosetron hydrochloride)
Lubiprostone
Lucentis (ranibizumab)
Lumigan (bimatoprost)
Lunestra (eszopiclone)
LyricaThis drug has as active FDA Safety Alert (pregabalin)

back to top

M
Macugen (pegaptanib)
MagnevistThis drug has as active FDA Safety Alert (gadopentetate dimeglumine)
Maraviroc
MavikThis drug has as active FDA Safety Alert (trandolapril)
MaxaltThis drug has as active FDA Safety Alert (rizatriptan benzoate)
MaxipimeThis drug has as active FDA Safety Alert (cefepime)
Mecasermin [rDNA origin]
Mecasermin-rinfabate
Meloxicam
Memantine
Metadate CD (methylphenidate HCl)
ylphenidate HCl)
Methylphenidate HCl
Methylphenidate transdermal
Mequinol
Micafungin
Micardis (telmisartan)
misartan)
MifeprexThis drug has as active FDA Safety Alert (mifepristone)
MifepristoneThis drug has as active FDA Safety Alert
Miglustat
MinirinThis drug has as active FDA Safety Alert (desmopressin)
MirtazapineThis drug has as active FDA Safety Alert
MisoprostolThis drug has as active FDA Safety Alert
Mobic (meloxicam)
Modafinil
MoexiprilThis drug has as active FDA Safety Alert
MonoprilThis drug has as active FDA Safety Alert (fosinopril)
Moxifloxacin
MultiHanceThis drug has as active FDA Safety Alert (gadobenate dimeglumine)
Mycamine (micafungin)
Mylotarg (gemtuzumab ozogamicin)

back to top

N
Namenda (memantine)
NaprosynThis drug has as active FDA Safety Alert (naproxen)
NaproxenThis drug has as active FDA Safety Alert
Naratriptan
Nesiritide recombinant
Nateglinide
Natrecor (nesiritide recombinant)
NefazodoneThis drug has as active FDA Safety Alert
Nelarabine
NeoTect Kit (technetium Tc 99m depreotide)
Nesiritide recombinant
NeurontinThis drug has as active FDA Safety Alert (gabapentin)
Nexavar (sorafenib)
Nitazoxanide
Nitisinone
Norelgestromin
NovoLog (insulin aspart recombinant)
Noxafil (posaconazole)

back to top

O
Olanzapine
Olanzapine/fluoxetineThis drug has as active FDA Safety Alert
Olmesartan medoxomil
Omacor (omega-3-acid ethyl esters)
OmalizumabThis drug has as active FDA Safety Alert
Omega-3-acid ethyl esters
Omnaris (cirlesonide)
OmniscanThis drug has as active FDA Safety Alert (gadodiamide)
OptiMARK (gadoversetamide)
Optison (perflutren protein-type A microspheres)
Orencia (abatacept)
Orfadin (nitisinone)
Orlistat
Ortho Evra (norelgestromin; ethinyl estradiol)
Oseltamivir phosphate
OsmoprepThis drug has as active FDA Safety Alert (sodium phosphate)
Oxaliplatin
OxcarbazepineThis drug has as active FDA Safety Alert


back to top

P
PaceroneThis drug has as active FDA Safety Alert (amiodarone)
Palifermin
Paliperidone
PamidronateThis drug has as active FDA Safety Alert
Panitumumab